Investor Directory
Elevage Medical Technologies logo

Elevage Medical Technologies

Investment firm

Stages
Growth
Based in
Austin, Texas
Focus
Devices & Robotics, Imaging & Diagnostics, Cardiovascular
Parent organisation
Patient Square Capital

Patient Square Capital, a health care investment firm, formed Elevage in May 2023 as a portfolio company and committed $300 million to it. Elevage invests in FDA regulated devices, including software as a medical device, diagnostics, lab tools, and health IT and tech enabled services. Michael Wasserman is chief executive, and Patient Square's Jim Momtazee chairs the board. In HTS coverage, Elevage joined Elucid's $55 million Series D in September 2026, alongside IAG Capital Partners, to fund commercial expansion of Elucid's AI software for cardiovascular plaque analysis.

Elevage provides capital and operating support to growth stage medical technology companies to help them reach regulatory approval and commercial scale.

Notable investments

Companies in the directory

The journey

How Elevage Medical Technologies got here, step by step.

  1. 2023

    Formed

    Patient Square Capital forms Elevage with a $300 million capital commitment.

Investors at similar stages

Related on The Signal

Your daily HealthTech Signal

No hype. Just signal.

Get the latest HealthTech news, understand why it matters, and see where the industry is headed.

5-minute read Delivered daily Unsubscribe anytime

Read by teams at companies like:

Mayo Clinic logoMayo ClinicCleveland Clinic logoCleveland ClinicJohns Hopkins logoJohns HopkinsKaiser Permanente logoKaiser PermanenteEpic logoEpicPhilips logoPhilipsMedtronic logoMedtronicGE HealthCare logoGE HealthCare